Brod, Meryl http://orcid.org/0000-0002-0663-5838
Højby Rasmussen, Michael
Vad, Knud
Alolga, Suzanne
Bushnell, Donald M. http://orcid.org/0000-0001-9226-1678
Bedoin, Jacques
Maniatis, Aristides http://orcid.org/0000-0002-6705-8579
Funding for this research was provided by:
Novo Nordisk
Article History
Accepted: 20 December 2020
First Online: 12 January 2021
Declarations
:
: This research was supported by Novo Nordisk.
: Meryl Brod, Suzanne Alolga, and Donald M. Bushnell are paid consultants to the pharmaceutical industry, including Novo Nordisk. Michael Højby Rasmussen, Knud Vad, and Jacques Bedoin are employees of Novo Nordisk, A/S. Aristides Maniatis is a principal investigator for Novo Nordisk, Ascendis, Pfizer/OPKO, Genentech, and Sandoz.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Copernicus Group IRB, tracking number TBG1-15-428) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all respondents who participated in the study.
: Not applicable.
: The data for the research presented in this publication may be available on a case-by-case basis upon reasonable request from the corresponding author.
: MB, MHR, KV, SA, and JB contributed to the study design and analysis and participated in manuscript preparation. DB conducted the analysis and participated in manuscript preparation. AM contributed to manuscript preparation and intellectual content. All authors read and approved the final version of the manuscript.